AbstractEndothelin-1 (ET-1) promotes atherosclerosis. We tested whether spleen tyrosine kinase (Syk) mediates tumor necrosis factor-α (TNF-α)-induced ET-1 upregulation in human aortic endothelial cells (HAECs) and sought to identify the signal pathways involved. TNF-α-induced reactive oxygen species (ROS) activated Syk and phosphatidylinositol 3-kinase (PI3K), which was required for the activation of AP-1 and subsequent ET-1 gene transcription. ROS mediated c-Jun NH2-terminal kinase (JNK) is also required for AP-1 activation, but Syk and PI3K regulated AP-1 activation independently of JNK. Through regulation of ET-1 production, Syk could be implicated in atherosclerosis
<div><p>Endothelial cells participate in inflammatory events leading to atherogenesis by regulating ...
BACKGROUND: Endothelial cell transformation to a thrombogenic and inflammatory phenotype plays an im...
Heme oxygenase-1 (HO-1), an enzyme degrading heme to carbon monoxide, iron, and biliverdin, has been...
AbstractEndothelin-1 (ET-1) promotes atherosclerosis. We tested whether spleen tyrosine kinase (Syk)...
Background/Aims: Toll-like receptor 4 (TLR4) interacts with endogenous substances as well as lipopol...
Objective. Atherosclerosis is a chronic inflammatory disease which is responsible for many clinical ...
Endothelin 1 (ET-1) is a key regulator of vascular homeostasis. We have recently reported that the p...
Endothelial dysfunction, partly induced by inflammatory mediators, is known to initiate and promote ...
Objective—Atherosclerosis is a focal disease that occurs predominantly at branches and bends of the ...
Human umbilical vein endothelial cells (HUVEC), like most normal cells, are resistant to tumor necro...
ABSTRACT Tumor necrosis factor (TNF) is a cytokine that mediates many pathophysiologial processes, i...
Objectives—Atherosclerosis preferentially occurs in areas of turbulent flow, whereas laminar flow is...
Atherosclerosis, a chronic inflammatory disease of arteries, occurs predominantly at regions of the ...
The signaling pathways that couple tumor necrosis factor-α (TNFα) receptors to functional, especiall...
Inflammation is a basic pathological mechanism leading to a variety of vascular diseases. The inflam...
<div><p>Endothelial cells participate in inflammatory events leading to atherogenesis by regulating ...
BACKGROUND: Endothelial cell transformation to a thrombogenic and inflammatory phenotype plays an im...
Heme oxygenase-1 (HO-1), an enzyme degrading heme to carbon monoxide, iron, and biliverdin, has been...
AbstractEndothelin-1 (ET-1) promotes atherosclerosis. We tested whether spleen tyrosine kinase (Syk)...
Background/Aims: Toll-like receptor 4 (TLR4) interacts with endogenous substances as well as lipopol...
Objective. Atherosclerosis is a chronic inflammatory disease which is responsible for many clinical ...
Endothelin 1 (ET-1) is a key regulator of vascular homeostasis. We have recently reported that the p...
Endothelial dysfunction, partly induced by inflammatory mediators, is known to initiate and promote ...
Objective—Atherosclerosis is a focal disease that occurs predominantly at branches and bends of the ...
Human umbilical vein endothelial cells (HUVEC), like most normal cells, are resistant to tumor necro...
ABSTRACT Tumor necrosis factor (TNF) is a cytokine that mediates many pathophysiologial processes, i...
Objectives—Atherosclerosis preferentially occurs in areas of turbulent flow, whereas laminar flow is...
Atherosclerosis, a chronic inflammatory disease of arteries, occurs predominantly at regions of the ...
The signaling pathways that couple tumor necrosis factor-α (TNFα) receptors to functional, especiall...
Inflammation is a basic pathological mechanism leading to a variety of vascular diseases. The inflam...
<div><p>Endothelial cells participate in inflammatory events leading to atherogenesis by regulating ...
BACKGROUND: Endothelial cell transformation to a thrombogenic and inflammatory phenotype plays an im...
Heme oxygenase-1 (HO-1), an enzyme degrading heme to carbon monoxide, iron, and biliverdin, has been...